JP2024536862A5 - - Google Patents

Info

Publication number
JP2024536862A5
JP2024536862A5 JP2024518802A JP2024518802A JP2024536862A5 JP 2024536862 A5 JP2024536862 A5 JP 2024536862A5 JP 2024518802 A JP2024518802 A JP 2024518802A JP 2024518802 A JP2024518802 A JP 2024518802A JP 2024536862 A5 JP2024536862 A5 JP 2024536862A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
substituted
pharmaceutically acceptable
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024518802A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024536862A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/077003 external-priority patent/WO2023049888A1/en
Publication of JP2024536862A publication Critical patent/JP2024536862A/ja
Publication of JP2024536862A5 publication Critical patent/JP2024536862A5/ja
Pending legal-status Critical Current

Links

JP2024518802A 2021-09-27 2022-09-26 Ｉｌ－１７の調節因子としてのベンズイミダゾール Pending JP2024536862A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163248569P 2021-09-27 2021-09-27
US63/248,569 2021-09-27
PCT/US2022/077003 WO2023049888A1 (en) 2021-09-27 2022-09-26 Benzimidazoles as modulators of il-17

Publications (2)

Publication Number Publication Date
JP2024536862A JP2024536862A (ja) 2024-10-08
JP2024536862A5 true JP2024536862A5 (cg-RX-API-DMAC7.html) 2025-10-01

Family

ID=83880137

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024518802A Pending JP2024536862A (ja) 2021-09-27 2022-09-26 Ｉｌ－１７の調節因子としてのベンズイミダゾール

Country Status (6)

Country Link
US (1) US20240376085A1 (cg-RX-API-DMAC7.html)
EP (1) EP4408530A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024536862A (cg-RX-API-DMAC7.html)
CN (1) CN118119613A (cg-RX-API-DMAC7.html)
CA (1) CA3233410A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023049888A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202430165A (zh) 2022-12-02 2024-08-01 丹麥商理奧藥品公司 Il-17之小分子調節劑
WO2025247285A1 (zh) * 2024-05-28 2025-12-04 西藏海思科制药有限公司 一种可抑制il-17a的杂环化合物制备及其用途
WO2026012492A1 (en) * 2024-07-12 2026-01-15 Anew Therapeutics Pte. Ltd. Heterocyclic compounds as il-17 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11472794B2 (en) * 2018-01-15 2022-10-18 UCB Biopharma SRL Fused imidazole derivatives as IL-17 modulators
CN110511213B (zh) * 2018-05-22 2021-10-19 成都先导药物开发股份有限公司 一种免疫调节剂

Similar Documents

Publication Publication Date Title
JP2024536862A5 (cg-RX-API-DMAC7.html)
JP2024536869A5 (cg-RX-API-DMAC7.html)
JP2024050527A5 (cg-RX-API-DMAC7.html)
JP2024536868A5 (cg-RX-API-DMAC7.html)
JP2023524018A5 (cg-RX-API-DMAC7.html)
JP2024536863A5 (cg-RX-API-DMAC7.html)
JP2023500328A5 (cg-RX-API-DMAC7.html)
JP2014037426A5 (cg-RX-API-DMAC7.html)
TW202208367A (zh) 作為ｉｌ－１７調節劑之咪唑并嗒類
JP2021535174A5 (cg-RX-API-DMAC7.html)
JP2023515617A5 (cg-RX-API-DMAC7.html)
JP2018520161A5 (cg-RX-API-DMAC7.html)
IL311751A (en) IL-17 imidazopyridazine inhibitory compounds
JP2017518959A5 (cg-RX-API-DMAC7.html)
JP2009534406A5 (cg-RX-API-DMAC7.html)
JP2021535177A5 (cg-RX-API-DMAC7.html)
JP2010540508A5 (cg-RX-API-DMAC7.html)
JP2021534106A5 (cg-RX-API-DMAC7.html)
RU2007101236A (ru) Новые гидантоиновые производные для лечения обструктивных заболеваний дыхательных путей
JP2004307440A (ja) ２−アミノ‐１，３‐プロパンジオール誘導体とその付加塩
JP2023512664A5 (cg-RX-API-DMAC7.html)
JP2022526553A5 (cg-RX-API-DMAC7.html)
JP2025160251A5 (cg-RX-API-DMAC7.html)
JP2009500409A (ja) 痛みを処置するためのα２アドレナリン作動剤
JP2023511152A5 (cg-RX-API-DMAC7.html)